结构和动态洞察力对联体识别和激活体静止素受体3的结构和动态洞察力
Xue Chen1,2, Sen Guo1,2, Ying-Ge Li1,2
1School of Life Sciences, Division of Life Sciences and Medicine, Joint Center for Biological Analytical Chemistry, the First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, 230026, China.
我们确定了与八丁结合的体静止素受体3 (SSTR3) 的冷EM结构,揭示了它如何识别连接体并激活. 这种结构和动态洞察力有助于设计更好的SSTR3向疗法.
科学领域:
- 结构生物学 结构生物学
- 分子药理学分子药理学
- 内分泌学 在内分泌学.
背景情况:
- 索马托斯塔丁受体3 (SSTR3) 调节激素释放和细胞增殖,使其成为垂体瘤和内分泌疾病的治疗点.
- 目前的体静电疗法受限于缺乏对SSTR3连接体识别和动态的分子理解.
研究的目的:
- 阐明连接体识别和SSTR3.3激活的分子机制.
- 为设计改进的SSTR3亚型选择性药物提供结构和动态见解.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定与烯胺结合的人类SSTR3-Gi复合物的结构.
- 突变性分析以确定关键的残留物,用于连接体亚型的选择性.
- 电子偏磁共振 (EPR) 谱学用于研究SSTR3的形态动态.
主要成果:
- 含有八胺的SSTR3-Gi复合物的冷EM结构在2.90 Å分辨率下得到解析.
- 关键残留物R2035·35 (SSTR3) 和F2947·35 (SSTR2) 被确定为关键的八基类型选择性.
- EPR光谱检测显示,在带结合或G蛋白合时,跨膜螺旋6 (TM6) 的活力和细胞外暴露增加.
结论:
- 这项研究为SSTR3激活和带结合提供了前所未有的结构和动态见解.
- 这些发现将指导新型,亚型选择性体静电药物的合理设计,这些药物在内分泌疾病和垂体瘤中具有增强的治疗潜力.
更多相关视频
12:43Monitoring Activation of the Antiviral Pattern Recognition Receptors RIG-I And PKR By Limited Protease Digestion and Native PAGE
Published on: July 29, 2014
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
相关概念视频
Ligand Binding and Linkage
Internal Receptors
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Olfactory Receptors: Location and Structure
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
